Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Neoplasms Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Italy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Survival Medicine & Life Sciences
Melanoma Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Alessandra Anna Affatato

Alessandra Anna Affatato

Person: Academic

No photo of Mattia Altini

Mattia Altini

Person: Academic

20052018
No photo of Daniele Andreis

Daniele Andreis

Person: Academic

20112018

Projects 2018 2018

Istituto Scientifico Romagnolo - GENETICA E AMBIENTE NELLO SVILUPPO E PROGRESSIONE DEI TUMORI E MECCANISMI INIBITORI. EXPOSOMICA, PREVENZIONE PRIMARIA E SECONDARIA

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

Istituto Scientifico Romagnolo - TERAPIE INNOVATIVE, TRIALS DI FASE I-III E DI STRATEGIA TERAPEUTICA BASATI SU MODELLI PRECLINICI, MECCANISMI ONCO-IMMUNOLOGICI, NANOVETTORI

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

Istituto Scientifico Romagnolo - APPROPRIATEZZA, ESITI, VALUE DEL FARMACO E MODELLI ORGANIZZATIVI FUNZIONALI ALLA CONTINUITA' DEI PERCORSI DIAGNOSTICO-TERAPEUTICI IN ONCOLOGIA

Ricerca, U.

1/1/18 → 12/30/18

Project: Other project

Research Output 1965 2019

Aneuploidy: Cancer strength or vulnerability?

Simonetti, G., Bruno, S., Padella, A., Tenti, E. & Martinelli, G., Jan 1 2019, In : International Journal of Cancer. 144, 1, p. 8-25 18 p.

Research output: Contribution to journal › Review article

DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients

Del Re, M., Cinieri, S., Michelucci, A., Salvadori, S., Loupakis, F., Schirripa, M., Cremolini, C., Crucitta, S., Barbara, C., Di Leo, A., Latiano, T. P., Pietrantonio, F., Di Donato, S., Simi, P., Passardi, A., De Braud, F., Altavilla, G., Zamagni, C., Bordonaro, R., Butera, A. & 6 othersMaiello, E., Pinto, C., Falcone, A., Mazzotti, V., Morganti, R. & Danesi, R., Jan 1 2019, In : Pharmacogenomics Journal.

Research output: Contribution to journal › Article

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

Passiglia, F., Cappuzzo, F., Alabiso, O., Bettini, A. C., Bidoli, P., Chiari, R., Defferrari, C., Delmonte, A., Finocchiaro, G., Francini, G., Gelsomino, F., Giannarelli, D., Giordano, M., Illiano, A., Livi, L., Martelli, O., Natoli, C., Puppo, G., Ricevuto, E., Roca, E. & 2 othersTurci, D. & Galetta, D., Jan 8 2019, In : British Journal of Cancer. 120, 1, p. 57-62 6 p.

Research output: Contribution to journal › Article